The annual ASCO assembly begins on the finish of the week, a convention that has usually offered a tailwind for biotech and pharma names.
Biotech has been a laggard this 12 months, gaining huge in February and March however declining and buying and selling in a uneven vary since then.
Financial institution of America analyst Geoff Meacham recognized three firms that would get a constructive reception on the assembly.
Elon Musk, the CEO of Tesla. Christophe Gateau/image alliance by way of Getty Pictures Tes…